|
1
|
Sanlorenzo M, Vujic I, Posch C, et al:
Melanoma immunotherapy. Cancer Biol Ther. 15:665–674. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Disis ML, Bernhard H and Jaffee EM: Use of
tumour-responsive T cells as cancer treatment. Lancet. 373:673–683.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yoo JW, Irvine DJ, Discher DE, et al:
Bio-inspired, bioengineered and biomimetic drug delivery carriers.
Nat Rev Drug Discov. 10:521–535. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Radford KJ, Tullett KM and Lahoud MH:
Dendritic cells and cancer immunotherapy. Curr Opin Immunol.
27:26–32. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Moore MW, Carbone FR and Bevan MJ:
Introduction of soluble protein into the class I pathway of antigen
processing and presentation. Cell. 54:777–785. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Oppenheim JJ: Cytokines: Past, present,
and future. Int J Hematol. 74:3–8. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Christian DA and Hunter CA:
Particle-mediated delivery of cytokines for immunotherapy.
Immunotherapy. 4:425–441. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Katzman SD, Hoyer KK, Dooms H, et al:
Opposing functions of IL-2 and IL-7 in the regulation of immune
responses. Cytokine. 56:116–121. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu S, Lizée G, Lou Y, et al: IL-21
synergizes with IL-7 to augment expansion and anti-tumor function
of cytotoxic T cells. Int Immunol. 19:1213–1221. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gou HF, Huang J, Shi HS, et al:
Chemo-immunotherapy with oxaliplatin and interleukin-7 inhibits
colon cancer metastasis in mice. PLoS One. 9:e857892014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Oyewumi MO, Kumar A and Cui Z:
Nano-microparticles as immune adjuvants: Correlating particle sizes
and the resultant immune responses. Expert Rev Vaccines.
9:1095–1107. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Krishnamachari Y, Geary SM, Lemke CD, et
al: Nanoparticle delivery systems in cancer vaccines. Pharm Res.
28:215–236. 2011. View Article : Google Scholar
|
|
13
|
Osada K, Christie RJ and Kataoka K:
Polymeric micelles from poly(ethylene glycol)-poly(amino acid)
block copolymer for drug and gene delivery. J R Soc Interface.
6(Suppl 3): S325–S339. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Matsumura Y and Kataoka K: Preclinical and
clinical studies of anticancer agent-incorporating polymer
micelles. Cancer Sci. 100:572–579. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yanase N, Toyota H, Hata K, et al:
OVA-bound nanoparticles induce OVA-specific IgG1, IgG2a, and IgG2b
responses with low IgE synthesis. Vaccine. 32:5918–5924. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Harada M, Ohuchi M, Hayashi T and Kato Y:
Prolonged circulation and in vivo efficacy of recombinant human
granulocyte colony-stimulating factor encapsulated in polymeric
micelles. J Control Release. 156:101–108. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
DeNardo DG, Andreu P and Coussens LM:
Interactions between lymphocytes and myeloid cells regulate pro-
versus anti-tumor immunity. Cancer Metastasis Rev. 29:309–316.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mahapatro A and Singh DK: Biodegradable
nanoparticles are excellent vehicle for site directed in-vivo
delivery of drugs and vaccines. J Nanobiotechnology. 9:552011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Andersen BM and Ohlfest JR: Increasing the
efficacy of tumor cell vaccines by enhancing cross priming. Cancer
Lett. 325:155–164. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Manolova V, Flace A, Bauer M, et al:
Nanoparticles target distinct dendritic cell populations according
to their size. Eur J Immunol. 38:1404–1413. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Möller P, Sun Y, Dorbic T, et al:
Vaccination with IL-7 gene-modified autologous melanoma cells can
enhance the anti-melanoma lytic activity in peripheral blood of
patients with a good clinical performance status: a clinical phase
I study. Br J Cancer. 77:1907–1916. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li J, Huston G and Swain SL: IL-7 promotes
the transition of CD4 effectors to persistent memory cells. J Exp
Med. 198:1807–1815. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Schluns KS, Kieper WC, Jameson SC and
Lefrançois L: Interleukin-7 mediates the homeostasis of naïve and
memory CD8 T cells in vivo. Nat Immunol. 1:426–432. 2000.
View Article : Google Scholar
|
|
24
|
Rochman Y, Spolski R and Leonard WJ: New
insights into the regulation of T cells by γc family
cytokines. Nat Rev Immunol. 9:480–490. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hussein MR: Tumour-infiltrating
lymphocytes and melanoma tumorigenesis: an insight. Br J Dermatol.
153:18–21. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Egeblad M, Nakasone ES and Werb Z: Tumors
as organs: Complex tissues that interface with the entire organism.
Dev Cell. 18:884–901. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
de Visser KE, Eichten A and Coussens LM:
Paradoxical roles of the immune system during cancer development.
Nat Rev Cancer. 6:24–37. 2006. View
Article : Google Scholar : PubMed/NCBI
|
